The wound that learns to build bone
Every implant is placed into a wound, and the body answers an osteotomy the way it answers any other injury — with the same ancient, conserved repair cascade it would mount in skin or muscle. What makes the peri-implant wound special is not a different biology but a different endpoint: instead of resolving in a fibrous scar, this wound, given a receptive titanium surface, resolves in bone bonded directly to that surface. The pivot on which that special outcome turns is the humble blood clot. The fibrin meshwork that fills the gap between bone and implant in the first minutes is not merely a plug to stop bleeding; it is the provisional scaffold along which osteogenic cells crawl to reach the implant and lay bone upon it.1
This chapter traces the four overlapping phases of repair — hemostasis, inflammation, proliferation, and remodeling — and then maps each one onto what is happening at the implant surface during the same window. Two ideas recur and are worth fixing from the outset. First, the phases overlap rather than run in strict sequence; the clot is still being remodeled while granulation tissue forms, and woven bone is already mineralizing while inflammation resolves. Second, the clot is load-bearing in a biological sense — its retention on the implant surface is the single event that decides whether bone forms on the implant (contact osteogenesis) or merely advances toward it from the host walls (distance osteogenesis).2
Soft tissue and bone repair through the same four-phase cascade. In soft tissue the proliferative phase yields granulation tissue and the remodeling phase yields a collagenous scar. In the peri-implant wound the proliferative phase yields osteoconduction and de novo bone formation on the surface, and the remodeling phase replaces disorganized woven bone with load-bearing lamellar bone. The difference is the destination tissue — bone, not scar — and the decisive variable is whether the fibrin scaffold stays anchored to the implant.
Four overlapping phases of healing
The figure below maps the four phases against a (non-linear) time axis from the moment of placement to roughly one year. Read it vertically to see which processes are co-active at any instant, and horizontally to follow a single phase from onset to resolution. Note how heavily the early events overlap: hemostasis is still resolving while inflammation peaks, and angiogenesis is well underway before the proliferative phase has handed off to remodeling.
Phase 1 — Hemostasis and the fibrin clot
Within seconds of the osteotomy, vasoconstriction limits blood loss and a platelet plug forms over the cut surfaces. The coagulation cascade then converts soluble fibrinogen to insoluble fibrin, polymerizing a three-dimensional meshwork that fills the gap between bone and implant. This clot does two jobs at once. It seals the wound, and it serves as a growth-factor depot: activated platelets degranulate, releasing PDGF and TGF-β (along with VEGF and fibronectin) that will direct the cells of every subsequent phase.1 At the implant, the decisive event is that the fibrin scaffold adheres to the surface. The micro-topography and wettability of modern titanium are engineered precisely so that fibrin attaches and is retained against the retractile forces of migrating cells — because that retained scaffold is the cable along which osteogenic cells will travel.2
Phase 2 — Inflammation
Over days one to seven the wound is cleaned and the next phase is orchestrated. Neutrophils arrive first, dominating the first 24–48 hours and clearing bacteria and debris. Macrophages follow; they debride and, more importantly, signal — releasing cytokines and growth factors that recruit fibroblasts and osteogenic progenitor cells toward the wound bed. The macrophage population transitions over this window from a pro-inflammatory M1 phenotype to a pro-regenerative M2 phenotype, the switch that licenses angiogenesis and tissue rebuilding.3 Inflammation is necessary, but it must resolve on schedule: a prolonged or excessive inflammatory phase — as with smoking, infection, or poorly controlled diabetes — delays the recruitment of repair cells and stalls everything downstream.
Phase 3 — Proliferation: granulation, angiogenesis, and de novo bone
From roughly day three onward, new tissue is built. Granulation tissue fills the defect and angiogenesis — the sprouting of new capillaries — delivers the oxygen and nutrients without which no new tissue, least of all bone, can be made. Fibroblasts lay down a provisional connective-tissue matrix. At the implant this is the pivotal window, where ordinary repair diverges into osseointegration through two linked events described in Davies' model. In osteoconduction, osteogenic cells migrate across the retained fibrin scaffold to reach the implant surface itself. Having arrived, they perform de novo bone formation: they secrete a mineralized, collagen-poor interfacial matrix — the cement line — and then woven bone directly on the surface. Osteoconduction plus de novo formation is what we call contact osteogenesis, and on an appropriate surface it culminates in bone bonding.12
Phase 4 — Remodeling and maturation
Over weeks to a year the initial repair is reorganized into mature, load-bearing tissue. Disorganized, mechanically weak woven bone is replaced by lamellar bone through coupled osteoclast–osteoblast activity that refines architecture along load lines; the matrix mineralizes further and strength rises over months. Clinically, this maturation is what underlies the slow rise in secondary (biological) stability after placement. De novo alveolar bone laid against the implant during proliferation matures here into the intimate, bonded bone-to-implant contact that defines a successfully integrated implant.3
Because the fibrin scaffold is the cable for osteogenic cell migration, every surgical choice that preserves it preserves contact osteogenesis. Atraumatic technique, adequate bleeding to seed a clot, primary stability so micromotion does not shear the clot from the surface, and a wettable surface that resists clot retraction all defend the same structure. Over-irrigation that flushes the clot, or a loose cover screw that pumps fluid across the surface, works directly against it.
- Treating the clot as disposable — aggressive curettage or irrigation that detaches fibrin from the surface forces bone to form at a distance instead of on the implant.
- Ignoring a prolonged inflammatory phase. In smokers and uncontrolled diabetics the M1→M2 transition stalls; loading on the calendar rather than the biology loads an unhealed site.
- Assuming the phases are sequential. Because they overlap, an insult in one phase (e.g. infection during inflammation) ripples forward into proliferation and remodeling.
Phase, timeframe, and the event at the implant
The table below condenses the cascade. Timeframes are approximate and overlap; they are slower in soft, grafted, or compromised sites. The right-hand column links each phase to the peri-implant event described in Davies' model, with an evidence grade for the strength of support behind each mapping.
| Phase | Timeframe | Key cells / events | At the implant surface | Evidence |
|---|---|---|---|---|
| Hemostasis | Minutes – hours | Platelets, fibrin clot, PDGF / TGF-β release | Fibrin scaffold adheres to surface | Foundational review |
| Inflammation | Days 1–7 | Neutrophils then macrophages (M1→M2); debridement & signaling | Clot retained; progenitor cells recruited | Foundational review |
| Proliferation | Days 3–14+ | Fibroblasts, angiogenesis, granulation tissue, woven bone | Histology Osteoconduction + de novo bone | Preclinical |
| Remodeling | Weeks – 1 year | Coupled osteoclasts / osteoblasts; woven → lamellar bone | Contact osteogenesis matures; bone bonding | Preclinical |
Phase explorer
Select any phase to review its dominant cells, molecular events, and — where relevant — what is happening at the implant surface during that window. On an implant, hemostasis and proliferation map directly onto osteoconduction and de novo bone formation.
Key terms
- Hemostasis
- The first phase of healing: vasoconstriction and a platelet plug, followed by conversion of fibrinogen to fibrin to form the clot that seals the wound.
- Fibrin scaffold
- The three-dimensional fibrin meshwork of the clot; on an implant it adheres to the surface and serves as the cable along which osteogenic cells migrate.
- Osteoconduction
- Migration of osteogenic cells across the fibrin / implant surface to reach the implant, the first of Davies' two healing phases.
- De novo bone formation
- Secretion by osteogenic cells of a mineralized cement-line matrix and woven bone directly on the implant surface.
- Contact osteogenesis
- The combined result of osteoconduction and de novo bone formation: new bone forming on the implant surface itself, leading to bone bonding.
- Granulation tissue
- The vascular, fibroblast-rich provisional tissue of the proliferative phase that fills a defect before mature tissue forms.
Self-Test
- Which growth factors does the clot release and from where?
- Where does osteoconduction sit in this timeline?
- How does this map onto primary vs secondary stability?
- Why does clot retention favor contact osteogenesis?
- How does surface roughness influence which mode dominates?
- What is a cement line and what is its role?
- How does excessive micromotion disrupt the clot?
- Why does surface wettability help clot adhesion?
- What growth factors does the clot supply and what do they do?
- Which specific phase is the bottleneck and why?
- How does the M1→M2 switch fit in?
- How would these host factors change your loading protocol?
- What is the role of the fibrin scaffold in osteoconduction?
- What is the cement line and why does it matter?
- What surface properties make bone bonding more likely?
References
- Davies JE. Understanding peri-implant endosseous healing. J Dent Educ. 2003;67(8):932–949. PMID: 12959168
- Terheyden H, Lang NP, Bierbaum S, Stadlinger B. Osseointegration — communication of cells. Clin Oral Implants Res. 2012;23(10):1127–1135. doi:10.1111/j.1600-0501.2011.02327.x
- Berglundh T, Abrahamsson I, Lang NP, Lindhe J. De novo alveolar bone formation adjacent to endosseous implants. Clin Oral Implants Res. 2003;14(3):251–262. doi:10.1034/j.1600-0501.2003.00972.x
Evidence grades: Foundational review Consensus Preclinical / Histology.